691
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis

, ORCID Icon, , ORCID Icon & ORCID Icon
Article: 2271574 | Received 27 Jul 2023, Accepted 11 Oct 2023, Published online: 23 Oct 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.